Which super funds hold BioScience Managers Pty Ltd?
As at 31 December 2025, 15 Australian super investment options in our dataset held BioScience Managers Pty Ltd, the largest weighting being 0.00% in Balanced (Accumulation) (CareSuper).
Options holding it
15
Largest weighting
0.00%
Balanced (Accumulation) · CareSuper
Australian super investment options disclosing a holding in BioScience Managers Pty Ltd. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| CareSuper | Accumulation | Balanced (Accumulation) | 0.00% | $2,195,879 | 31 December 2025 |
| CareSuper | Accumulation | Growth (Accumulation) | 0.00% | $225,455 | 31 December 2025 |
| CareSuper | Retirement | Balanced (Income) | 0.00% | $140,331 | 31 December 2025 |
| CareSuper | Accumulation | Sustainable Balanced (Accumulation) | 0.00% | $26,448 | 31 December 2025 |
| CareSuper | Retirement | Conservative Balanced (Income) | 0.00% | $21,191 | 31 December 2025 |
| CareSuper | Accumulation | Conservative Balanced (Accumulation) | 0.00% | $19,539 | 31 December 2025 |
| CareSuper | Retirement | Growth (Income) | 0.00% | $15,905 | 31 December 2025 |
| CareSuper | Retirement | Sustainable Balanced (Income) | 0.00% | $11,224 | 31 December 2025 |
| CareSuper | Accumulation | Capital Stable (Accumulation) | 0.00% | $8,811 | 31 December 2025 |
| CareSuper | Retirement | Capital Stable (Income) | 0.00% | $7,571 | 31 December 2025 |
| CareSuper | Retirement | Long Term Pension (Income) | 0.00% | $4,013 | 31 December 2025 |
| CareSuper | Accumulation | Alternative Growth (Accumulation) | 0.00% | $2,843 | 31 December 2025 |
| CareSuper | Defined benefit | LCC HCC (Defined Benefit) | 0.00% | $1,839 | 31 December 2025 |
| CareSuper | Defined benefit | Quadrant (Defined Benefit) | 0.00% | $823 | 31 December 2025 |
| CareSuper | Retirement | Alternative Growth (Income) | 0.00% | $415 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.